Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer’s Disease

Depression and dementia are major public health problems. Major depressive disorder (MDD) and Alzheimer’s disease (AD) reciprocally elevate the risk for one another. No effective drug is available to treat AD and about one-third of depressive patients show treatment resistance. The biological connec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trends in molecular medicine 2020-09, Vol.26 (9), p.803-818
Hauptverfasser: Berger, Thomas, Lee, Hyunah, Young, Allan H., Aarsland, Dag, Thuret, Sandrine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 818
container_issue 9
container_start_page 803
container_title Trends in molecular medicine
container_volume 26
creator Berger, Thomas
Lee, Hyunah
Young, Allan H.
Aarsland, Dag
Thuret, Sandrine
description Depression and dementia are major public health problems. Major depressive disorder (MDD) and Alzheimer’s disease (AD) reciprocally elevate the risk for one another. No effective drug is available to treat AD and about one-third of depressive patients show treatment resistance. The biological connection between MDD and AD is still unclear. Uncovering this link might open novel ways of treatment and prevention to improve patient healthcare. Here, we discuss recent studies specifically on the role of human adult hippocampal neurogenesis (AHN) in MDD and AD. We compare diverse approaches to analyse the effect of MDD and AD on human AHN and analyse different studies implicating the role of human AHN as a potential converging mechanism in MDD and AD. Human AHN is severely depleted in both MDD and AD indicated by reduction of distinct neurogenic markers and hippocampal volume.Human AHN might be a converging mechanism for MDD and AD, indicating clinical as well as genetic links.Human AHN might display an interesting therapeutic target to potentially develop novel treatment strategies for MDD and AD.
doi_str_mv 10.1016/j.molmed.2020.03.010
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_471224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1471491420301003</els_id><sourcerecordid>2404373453</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-7bc721c64d811ce6bde9156ad8fb801fdb384df84933d0a8e26dc0d1d57251ac3</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhiMEoqXwBgjlyCVhxnYS54K0agtFKnChEjfLsSfgJYmDvSmCE6_B6_EkeJXdcoKTR57vm5Hmz7KnCCUC1i-25eiHkWzJgEEJvASEe9kpigYL0bYf79_VKE6yRzFuAbBqGvkwO-FMoGwYP81uNnYZdvmVm2dv9DjrIX9HS_CfaKLoYu6m_K3e-pBf0BwoRndL-YWLPlgKuZ5svhl-fCY3Uvj981fct0hHepw96PUQ6cnhPctuXl1-OL8qrt-_fnO-uS6MqGBXNJ1pGJpaWIloqO4stVjV2sq-k4C97bgUtpei5dyClsRqa8CirRpWoTb8LCvWufEbzUun5uBGHb4rr506fH1JFal0CMZE4tt_8nPw9q90FFGIGkFISO7z1U3g14XiTo0uGhoGPZFfomICBG-4qHhCxYqa4GMM1N8tQlD78NRWreGpfXgKuErhJe3ZYcPS7XtH6ZhWAl6uAKWb3joKKhpHkyHrApmdst79f8Mf1Q-vwA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2404373453</pqid></control><display><type>article</type><title>Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer’s Disease</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Berger, Thomas ; Lee, Hyunah ; Young, Allan H. ; Aarsland, Dag ; Thuret, Sandrine</creator><creatorcontrib>Berger, Thomas ; Lee, Hyunah ; Young, Allan H. ; Aarsland, Dag ; Thuret, Sandrine</creatorcontrib><description>Depression and dementia are major public health problems. Major depressive disorder (MDD) and Alzheimer’s disease (AD) reciprocally elevate the risk for one another. No effective drug is available to treat AD and about one-third of depressive patients show treatment resistance. The biological connection between MDD and AD is still unclear. Uncovering this link might open novel ways of treatment and prevention to improve patient healthcare. Here, we discuss recent studies specifically on the role of human adult hippocampal neurogenesis (AHN) in MDD and AD. We compare diverse approaches to analyse the effect of MDD and AD on human AHN and analyse different studies implicating the role of human AHN as a potential converging mechanism in MDD and AD. Human AHN is severely depleted in both MDD and AD indicated by reduction of distinct neurogenic markers and hippocampal volume.Human AHN might be a converging mechanism for MDD and AD, indicating clinical as well as genetic links.Human AHN might display an interesting therapeutic target to potentially develop novel treatment strategies for MDD and AD.</description><identifier>ISSN: 1471-4914</identifier><identifier>ISSN: 1471-499X</identifier><identifier>EISSN: 1471-499X</identifier><identifier>DOI: 10.1016/j.molmed.2020.03.010</identifier><identifier>PMID: 32418723</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>adult hippocampal neurogenesis ; Alzheimer Disease - physiopathology ; Alzheimer’s disease ; Animals ; Depressive Disorder, Major - physiopathology ; Hippocampus - physiopathology ; Humans ; major depressive disorder ; Medicin och hälsovetenskap ; Neurogenesis - physiology</subject><ispartof>Trends in molecular medicine, 2020-09, Vol.26 (9), p.803-818</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-7bc721c64d811ce6bde9156ad8fb801fdb384df84933d0a8e26dc0d1d57251ac3</citedby><cites>FETCH-LOGICAL-c450t-7bc721c64d811ce6bde9156ad8fb801fdb384df84933d0a8e26dc0d1d57251ac3</cites><orcidid>0000-0003-1260-8083</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.molmed.2020.03.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32418723$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:144610480$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Berger, Thomas</creatorcontrib><creatorcontrib>Lee, Hyunah</creatorcontrib><creatorcontrib>Young, Allan H.</creatorcontrib><creatorcontrib>Aarsland, Dag</creatorcontrib><creatorcontrib>Thuret, Sandrine</creatorcontrib><title>Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer’s Disease</title><title>Trends in molecular medicine</title><addtitle>Trends Mol Med</addtitle><description>Depression and dementia are major public health problems. Major depressive disorder (MDD) and Alzheimer’s disease (AD) reciprocally elevate the risk for one another. No effective drug is available to treat AD and about one-third of depressive patients show treatment resistance. The biological connection between MDD and AD is still unclear. Uncovering this link might open novel ways of treatment and prevention to improve patient healthcare. Here, we discuss recent studies specifically on the role of human adult hippocampal neurogenesis (AHN) in MDD and AD. We compare diverse approaches to analyse the effect of MDD and AD on human AHN and analyse different studies implicating the role of human AHN as a potential converging mechanism in MDD and AD. Human AHN is severely depleted in both MDD and AD indicated by reduction of distinct neurogenic markers and hippocampal volume.Human AHN might be a converging mechanism for MDD and AD, indicating clinical as well as genetic links.Human AHN might display an interesting therapeutic target to potentially develop novel treatment strategies for MDD and AD.</description><subject>adult hippocampal neurogenesis</subject><subject>Alzheimer Disease - physiopathology</subject><subject>Alzheimer’s disease</subject><subject>Animals</subject><subject>Depressive Disorder, Major - physiopathology</subject><subject>Hippocampus - physiopathology</subject><subject>Humans</subject><subject>major depressive disorder</subject><subject>Medicin och hälsovetenskap</subject><subject>Neurogenesis - physiology</subject><issn>1471-4914</issn><issn>1471-499X</issn><issn>1471-499X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1DAQhiMEoqXwBgjlyCVhxnYS54K0agtFKnChEjfLsSfgJYmDvSmCE6_B6_EkeJXdcoKTR57vm5Hmz7KnCCUC1i-25eiHkWzJgEEJvASEe9kpigYL0bYf79_VKE6yRzFuAbBqGvkwO-FMoGwYP81uNnYZdvmVm2dv9DjrIX9HS_CfaKLoYu6m_K3e-pBf0BwoRndL-YWLPlgKuZ5svhl-fCY3Uvj981fct0hHepw96PUQ6cnhPctuXl1-OL8qrt-_fnO-uS6MqGBXNJ1pGJpaWIloqO4stVjV2sq-k4C97bgUtpei5dyClsRqa8CirRpWoTb8LCvWufEbzUun5uBGHb4rr506fH1JFal0CMZE4tt_8nPw9q90FFGIGkFISO7z1U3g14XiTo0uGhoGPZFfomICBG-4qHhCxYqa4GMM1N8tQlD78NRWreGpfXgKuErhJe3ZYcPS7XtH6ZhWAl6uAKWb3joKKhpHkyHrApmdst79f8Mf1Q-vwA</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Berger, Thomas</creator><creator>Lee, Hyunah</creator><creator>Young, Allan H.</creator><creator>Aarsland, Dag</creator><creator>Thuret, Sandrine</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><orcidid>https://orcid.org/0000-0003-1260-8083</orcidid></search><sort><creationdate>20200901</creationdate><title>Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer’s Disease</title><author>Berger, Thomas ; Lee, Hyunah ; Young, Allan H. ; Aarsland, Dag ; Thuret, Sandrine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-7bc721c64d811ce6bde9156ad8fb801fdb384df84933d0a8e26dc0d1d57251ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>adult hippocampal neurogenesis</topic><topic>Alzheimer Disease - physiopathology</topic><topic>Alzheimer’s disease</topic><topic>Animals</topic><topic>Depressive Disorder, Major - physiopathology</topic><topic>Hippocampus - physiopathology</topic><topic>Humans</topic><topic>major depressive disorder</topic><topic>Medicin och hälsovetenskap</topic><topic>Neurogenesis - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berger, Thomas</creatorcontrib><creatorcontrib>Lee, Hyunah</creatorcontrib><creatorcontrib>Young, Allan H.</creatorcontrib><creatorcontrib>Aarsland, Dag</creatorcontrib><creatorcontrib>Thuret, Sandrine</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Trends in molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berger, Thomas</au><au>Lee, Hyunah</au><au>Young, Allan H.</au><au>Aarsland, Dag</au><au>Thuret, Sandrine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer’s Disease</atitle><jtitle>Trends in molecular medicine</jtitle><addtitle>Trends Mol Med</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>26</volume><issue>9</issue><spage>803</spage><epage>818</epage><pages>803-818</pages><issn>1471-4914</issn><issn>1471-499X</issn><eissn>1471-499X</eissn><abstract>Depression and dementia are major public health problems. Major depressive disorder (MDD) and Alzheimer’s disease (AD) reciprocally elevate the risk for one another. No effective drug is available to treat AD and about one-third of depressive patients show treatment resistance. The biological connection between MDD and AD is still unclear. Uncovering this link might open novel ways of treatment and prevention to improve patient healthcare. Here, we discuss recent studies specifically on the role of human adult hippocampal neurogenesis (AHN) in MDD and AD. We compare diverse approaches to analyse the effect of MDD and AD on human AHN and analyse different studies implicating the role of human AHN as a potential converging mechanism in MDD and AD. Human AHN is severely depleted in both MDD and AD indicated by reduction of distinct neurogenic markers and hippocampal volume.Human AHN might be a converging mechanism for MDD and AD, indicating clinical as well as genetic links.Human AHN might display an interesting therapeutic target to potentially develop novel treatment strategies for MDD and AD.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32418723</pmid><doi>10.1016/j.molmed.2020.03.010</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0003-1260-8083</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1471-4914
ispartof Trends in molecular medicine, 2020-09, Vol.26 (9), p.803-818
issn 1471-4914
1471-499X
1471-499X
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_471224
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects adult hippocampal neurogenesis
Alzheimer Disease - physiopathology
Alzheimer’s disease
Animals
Depressive Disorder, Major - physiopathology
Hippocampus - physiopathology
Humans
major depressive disorder
Medicin och hälsovetenskap
Neurogenesis - physiology
title Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer’s Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A40%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adult%20Hippocampal%20Neurogenesis%20in%20Major%20Depressive%20Disorder%20and%20Alzheimer%E2%80%99s%20Disease&rft.jtitle=Trends%20in%20molecular%20medicine&rft.au=Berger,%20Thomas&rft.date=2020-09-01&rft.volume=26&rft.issue=9&rft.spage=803&rft.epage=818&rft.pages=803-818&rft.issn=1471-4914&rft.eissn=1471-499X&rft_id=info:doi/10.1016/j.molmed.2020.03.010&rft_dat=%3Cproquest_swepu%3E2404373453%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2404373453&rft_id=info:pmid/32418723&rft_els_id=S1471491420301003&rfr_iscdi=true